Attitudes of Israeli gynecologists towards the levonorgestrel-releasing intrauterine system: A questionnaire survey

European Journal of Contraception and Reproductive Health Care

Volumn 9, Issue 1, 2004, Pages 29-33

  Ben Haroush, A ^a   Oron, G ^a   Yogev, Y ^a   Yeshaya, A ^a   Kaplan, B ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Contraception; Intrauterine devices; Israel; Levonorgestrel releasing intrauterine system; Menorrhagia; Physician questionnaire

Indexed keywords

COPPER INTRAUTERINE DEVICE; LEVONORGESTREL;

ATTITUDE; BREAKTHROUGH BLEEDING; CONTROLLED STUDY; ENDOMETRIUM; ESTROGEN THERAPY; GYNECOLOGY; HEALTH SURVEY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; ISRAEL; MAJOR CLINICAL STUDY; MENORRHAGIA; OUTPATIENT DEPARTMENT; PAIN; PATIENT SATISFACTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SELF EVALUATION; SIDE EFFECT;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; GYNECOLOGY; HUMANS; INTRAUTERINE DEVICES, COPPER; ISRAEL; LEVONORGESTREL; MENORRHAGIA; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 2942562838     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/13625180410001698753     Document Type: Review

References (22)

1. Rinehart W. IUDs - an update. Pop Rep B 1995:1-35
2. Stanwood NL, Garrett JM, Konrad TR. Obstetrician-gynecologists and the intrauterine device: a survey of attitudes and practice. Obstet Gynecol 2002;99:275-80
3. American College of Obstetricians and Gynecologists. The intrauterine device. ACOG Technical Bulletin no. 164. Washington, DC: American College of Obstetricians and Gynecologists, 1992
4. Westhoff C. The IUD in evolution. Obstet Gynecol Surv 1996;51:S20-4
5. Kooiker CH, Scutchfield FD. Barriers to prescribing the copper T 380A intrauterine device by physicians. West J Med 1990;153:279-82
6. Westhoff C, Marks F, Rosenfield A, Roig A, Nicholas A. Clinical and legal factors influencing IUD use in the United States. In Bardin C, Mishell D, eds. Proceedings from the Fourth International Conference on IUDs. Boston: Butterworth-Heinemann, 1994:100-8
7. Piccinino LJ, Mosher WD. Trends in contraceptive use in the United States: 1982-1995. Fam Plan Perspect 1998;30:4-10
8. Kessel E. Pelvic inflammatory disease with intrauterine device use: a reassessment. Fertil Steril 1989;51:1-11
9. Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000;356:1013-19
10. Arias RD. Compelling reasons for recommending IUDs to any woman of reproductive age. Int J Fertil Women Med 2002;47:87-95
11. Glasier AF, Smith KB, van der Spuy ZM, et al. Amenorrhea associated with contraception - an international study on acceptability. Contraception 2003;67:1-8
12. Xiao B, Wu SC, Chong J, Zeng T, Han LH, Luukkainen T. Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia. Fertil Steril 2003;79:963-9
13. Monteiro I, Bahamondes L, Diaz J, Perrotti M, Petta C. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study (1). Contraception 2002;65:325-8
14. Nagrani R, Bowen-Simpkins P, Barrington JW. Can the levonorgestrel intrauterine system replace surgical treatment for the management of menorrhagia? Br J Obstet Gynaecol 2002;109:345-7
15. Istre O, Trolle B. Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertil Steril 2001;76:304-9
16. Cameron IT. The levonorgestrel intrauterine system: the benefits of reduced bleeding. Eur J Contracept Reprod Health Care 2001;6(Suppl 1):27-32
17. Zalel Y, Gamzu R, Shulman A, Achiron R, Schiff G, Lidor A. The progestative effect of the levonorgestrel-releasing intrauterine system - when does it manifest? Contraception 2003;67:473-6
18. Bahamondes L, Ribeiro-Huguet P, de Andrade KC, Leon-Martins O, Petta CA. Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma. Acta Obstet Gynecol Scand 2003;82:580-2
19. Wildemeersch D, Dhont M. Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system. Am J Obstet Gynecol 2003;188:1297-8
20. Dubuisson JB, Mugnier E. Acceptability of the levonorgestrel-releasing intrauterine system after discontinuation of previous contraception: results of a French clinical study in women aged 35 to 45 years. Contraception 2002;66:121-8
21. Harrison-Woolrych M, Zhou L, Coulter D. Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand. N Z Med J 2003 8;116:U538
22. Olsson HL, Ingvar C, Bladstrom A. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden. Cancer 2003;97:1387-92